Ron Cohen
2022
In 2022, Ron Cohen earned a total compensation of $984.2K as President and Chief Executive Officer at Acorda Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $350,000 |
|---|---|
| Salary | $625,000 |
| Other | $9,150 |
| Total | $984,150 |
Cohen received $625K in salary, accounting for 64% of the total pay in 2022.
Cohen also received $350K in non-equity incentive plan and $9.2K in other compensation.
Rankings
In 2022, Ron Cohen's compensation ranked 3,070th out of 5,756 executives tracked by ExecPay. In other words, Cohen earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,070 out of 5,756 | 47th |
Division Manufacturing | 1,726 out of 3,133 | 45th |
Major group Chemicals And Allied Products | 810 out of 1,419 | 43rd |
Industry group Drugs | 756 out of 1,320 | 43rd |
Industry Biological Products, Except Diagnostic Substances | 182 out of 291 | 38th |
Pay ratio
| Ron Cohen's Pay | $984,150 |
|---|---|
| Median Employee's Pay | $218,380 |
| Pay Ratio | 5to 1 |
In 2022, the annual total compensation of Ron Cohen was $984,150.
The annual total compensation of the median employee at Acorda Therapeutics was $218,380.
The ratio of Ron Cohen's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 27, 2023.
Cohen's colleagues
We found three more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2022.
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019